UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

Leukemia, 2011-05, Vol.25 (5), p.828-837

2011

Volltextzugriff (PDF)

Effector γδ T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma

Leukemia, 2005-04, Vol.19 (4), p.664-670

2005

Volltextzugriff (PDF)

2.37 Accelerated Activity of the Mevalonate Pathway Supports the Immune Escape and Multidrug- Resistance Phenotype of IGHV Unmutated Chronic Lymphocytic Leukemia Cells

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S182-S182

2011

Volltextzugriff (PDF)

2.28 Identification by Serological Proteome Analysis (SERPA) of Novel Tumor Associated Antigens in Chronic Lymphocytic Leukemia (CLL)

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S176-S177

2011

Volltextzugriff (PDF)

Effector gamma delta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma

Leukemia, 2005-04, Vol.19 (4), p.664-670

2005

Volltextzugriff (PDF)

Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1‐like regulatory T cells

European journal of immunology, 2005-04, Vol.35 (4), p.1155-1163

2005

Volltextzugriff (PDF)

Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy

Blood, 1999-07, Vol.94 (2), p.673-683

1999

Volltextzugriff (PDF)

Generation of anti‐tumour activity by OKT3‐stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis

British journal of haematology, 1994-07, Vol.87 (3), p.494-502

1994

Volltextzugriff (PDF)

Severe and long‐lasting disruption of T‐cell receptor diversity in human myeloma after high‐dose chemotherapy and autologous peripheral blood progenitor cell infusion

British journal of haematology, 2001-06, Vol.113 (4), p.1051-1059

2001

Volltextzugriff (PDF)

Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma

Leukemia, 2005-04, Vol.19 (4), p.664-670

2005

Volltextzugriff (PDF)

Effector T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma

Leukemia, 2005-04, Vol.19 (4), p.664-670

2005

Volltextzugriff (PDF)

Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking signal transducers with ecto-enzyme activities

The Journal of immunology (1950), 1996-11, Vol.157 (10), p.4354

1996

Volltextzugriff (PDF)

Distribution of T-cell signalling molecules in human myeloma

British journal of haematology, 1997-06, Vol.97 (4), p.815-820

1997

Volltextzugriff (PDF)

Increased expression of non‐functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients

British journal of haematology, 2000-04, Vol.109 (1), p.46-53

2000

Volltextzugriff (PDF)

CD38 Stimulation Lowers the Activation Threshold and Enhances the Alloreactivity of Cord Blood T Cells by Activating the Phosphatidylinositol 3-Kinase Pathway and Inducing CD73 Expression

The Journal of immunology (1950), 1999-05, Vol.162 (10), p.6238-6246

1999

Volltextzugriff (PDF)

Detection of Hyperreactive T Cells in Multiple Myeloma by Multivalent Cross-Linking of the CD3/TCR Complex

Blood, 1991-10, Vol.78 (7), p.1770-1780

1991

Volltextzugriff (PDF)

Idiotype vaccination in human myeloma : Generation of tumor-specific immune responses after high-dose chemotherapy

Blood, 1999-07, Vol.94 (2), p.673-683

1999

Volltextzugriff (PDF)

Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells

Blood, 1993-09, Vol.82 (6), p.1787-1797

1993

Volltextzugriff (PDF)

Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells

Blood, 1993-09, Vol.82 (6), p.1787-1797

1993

Volltextzugriff (PDF)

Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex [see comments]

Blood, 1991-10, Vol.78 (7), p.1770-1780

1991

Volltextzugriff (PDF)

Rapid generation of antiplasma cell acitivity in the bone marrow of myeloma patients by CD3-activited T cells

Blood, 1993, Vol.82 (6), p.1787-1797

1993

Volltextzugriff (PDF)

Sequential administration of OKT3 (anti-CD3) and interleukin-2 in two patients with chemoresistant hematological disease

European journal of haematology, 1992-09, Vol.49 (3), p.150-152

1992

Volltextzugriff (PDF)

Sequential administration of OKT3 (anti-CD3) and interleukin-2 in two patients with chemoresistant hematological disease

European journal of haematology, 1992, Vol.49 (3), p.150-152

1992

Volltextzugriff (PDF)

228 Investigating the Transitionary Process from Pediatric to Adult Care and Improving Transitional Readiness for Youth with Sickle Cell Disease (SCD) through Co-Designing an Intervention

Journal of clinical and translational science, 2024-04, Vol.8 (s1), p.68-69

2024

Volltextzugriff (PDF)

Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells

The Journal of immunology (1950), 2011-08, Vol.187 (4), p.1578-1590

2011

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(56)
Berichte
(1)

Sprache

Englisch
(57)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(18)
Hematology
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Multiple Myeloma - Immunology
(10)
T-Lymphocytes - Immunology
(7)
Hematologic And Hematopoietic Diseases
(6)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(5)
Adult
(4)
Aged
(4)
Cells, Cultured
(4)
Female
(4)
Immunology
(4)
Micronutrient
(4)
Oncology
(4)
T-Lymphocyte Subsets - Immunology
(4)
Animals
(3)
Antigens, Cd - Immunology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

Effector γδ T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma

2.37 Accelerated Activity of the Mevalonate Pathway Supports the Immune Escape and Multidrug- Resistance Phenotype of IGHV Unmutated Chronic Lymphocytic Leukemia Cells

2.28 Identification by Serological Proteome Analysis (SERPA) of Novel Tumor Associated Antigens in Chronic Lymphocytic Leukemia (CLL)

Effector gamma delta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma

Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1‐like regulatory T cells

Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy

Generation of anti‐tumour activity by OKT3‐stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis

Severe and long‐lasting disruption of T‐cell receptor diversity in human myeloma after high‐dose chemotherapy and autologous peripheral blood progenitor cell infusion

Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma

Effector T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma

Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking signal transducers with ecto-enzyme activities

Distribution of T-cell signalling molecules in human myeloma

Increased expression of non‐functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients

CD38 Stimulation Lowers the Activation Threshold and Enhances the Alloreactivity of Cord Blood T Cells by Activating the Phosphatidylinositol 3-Kinase Pathway and Inducing CD73 Expression

Detection of Hyperreactive T Cells in Multiple Myeloma by Multivalent Cross-Linking of the CD3/TCR Complex

Idiotype vaccination in human myeloma : Generation of tumor-specific immune responses after high-dose chemotherapy

Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells

Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells

Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex [see comments]

Rapid generation of antiplasma cell acitivity in the bone marrow of myeloma patients by CD3-activited T cells

Sequential administration of OKT3 (anti-CD3) and interleukin-2 in two patients with chemoresistant hematological disease

Sequential administration of OKT3 (anti-CD3) and interleukin-2 in two patients with chemoresistant hematological disease

228 Investigating the Transitionary Process from Pediatric to Adult Care and Improving Transitional Readiness for Youth with Sickle Cell Disease (SCD) through Co-Designing an Intervention

Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells

Suchergebnisse filtern